| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Tract Infections | 34 | 2019 | 1013 | 1.900 |
Why?
|
| Common Cold | 3 | 2022 | 63 | 1.740 |
Why?
|
| Respiratory Syncytial Viruses | 42 | 2000 | 168 | 1.510 |
Why?
|
| Infectious Disease Transmission, Vertical | 38 | 2017 | 1359 | 1.500 |
Why?
|
| Coronavirus | 5 | 2013 | 156 | 1.470 |
Why?
|
| Respirovirus Infections | 24 | 1993 | 51 | 1.340 |
Why?
|
| HIV Infections | 82 | 2017 | 17564 | 1.040 |
Why?
|
| Zidovudine | 28 | 2016 | 625 | 0.970 |
Why?
|
| Coronavirus 229E, Human | 2 | 2022 | 16 | 0.910 |
Why?
|
| HIV-1 | 49 | 2010 | 6966 | 0.870 |
Why?
|
| Paramyxoviridae Infections | 10 | 2004 | 57 | 0.860 |
Why?
|
| Anti-HIV Agents | 35 | 2017 | 4567 | 0.750 |
Why?
|
| Pregnancy Complications, Infectious | 27 | 2017 | 2181 | 0.660 |
Why?
|
| AIDS-Related Opportunistic Infections | 6 | 2004 | 664 | 0.590 |
Why?
|
| Coronavirus Infections | 5 | 2013 | 3116 | 0.510 |
Why?
|
| Antigens, Viral | 21 | 1999 | 992 | 0.500 |
Why?
|
| Acquired Immunodeficiency Syndrome | 18 | 2006 | 2203 | 0.500 |
Why?
|
| Pneumonia | 8 | 2019 | 2162 | 0.460 |
Why?
|
| Antiretroviral Therapy, Highly Active | 13 | 2013 | 1903 | 0.440 |
Why?
|
| RNA, Viral | 23 | 2010 | 2865 | 0.410 |
Why?
|
| Viral Tropism | 1 | 2013 | 102 | 0.410 |
Why?
|
| Infant | 104 | 2017 | 36497 | 0.410 |
Why?
|
| HIV Core Protein p24 | 10 | 2003 | 247 | 0.370 |
Why?
|
| Severe Acute Respiratory Syndrome | 3 | 2013 | 137 | 0.360 |
Why?
|
| CD4 Lymphocyte Count | 22 | 2013 | 2596 | 0.360 |
Why?
|
| HIV Protease Inhibitors | 6 | 2005 | 432 | 0.350 |
Why?
|
| Reverse Transcriptase Inhibitors | 7 | 2010 | 622 | 0.340 |
Why?
|
| HIV | 6 | 2001 | 1596 | 0.340 |
Why?
|
| Nevirapine | 6 | 2015 | 273 | 0.330 |
Why?
|
| Coronaviridae | 6 | 2004 | 13 | 0.330 |
Why?
|
| Viral Load | 20 | 2013 | 3399 | 0.320 |
Why?
|
| Virus Diseases | 16 | 1984 | 723 | 0.320 |
Why?
|
| HIV Seropositivity | 9 | 2000 | 963 | 0.310 |
Why?
|
| Ritonavir | 4 | 2005 | 330 | 0.290 |
Why?
|
| Infant, Newborn | 57 | 2017 | 26395 | 0.290 |
Why?
|
| Coronaviridae Infections | 3 | 2004 | 10 | 0.290 |
Why?
|
| Bocavirus | 1 | 2006 | 1 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 9 | 2009 | 4642 | 0.280 |
Why?
|
| Parainfluenza Virus 1, Human | 4 | 1992 | 25 | 0.270 |
Why?
|
| Central Nervous System Diseases | 2 | 2009 | 521 | 0.260 |
Why?
|
| Dapsone | 3 | 2001 | 56 | 0.250 |
Why?
|
| Viremia | 5 | 2006 | 725 | 0.250 |
Why?
|
| Child, Preschool | 77 | 2010 | 42623 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 9 | 2005 | 1797 | 0.250 |
Why?
|
| Polymerase Chain Reaction | 9 | 2015 | 6091 | 0.240 |
Why?
|
| Stavudine | 4 | 2010 | 85 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 22 | 2000 | 3816 | 0.240 |
Why?
|
| Antibodies, Viral | 30 | 1999 | 3212 | 0.240 |
Why?
|
| Fluorescent Antibody Technique | 18 | 1991 | 2477 | 0.230 |
Why?
|
| Metapneumovirus | 1 | 2004 | 28 | 0.230 |
Why?
|
| Child | 87 | 2019 | 80863 | 0.220 |
Why?
|
| Gene Products, gag | 8 | 2006 | 318 | 0.220 |
Why?
|
| Humans | 228 | 2022 | 768451 | 0.200 |
Why?
|
| HIV Antibodies | 6 | 1996 | 1341 | 0.200 |
Why?
|
| Influenza, Human | 9 | 2000 | 1540 | 0.200 |
Why?
|
| Respirovirus | 5 | 1987 | 31 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 3 | 1999 | 839 | 0.200 |
Why?
|
| Protein Deficiency | 2 | 1992 | 59 | 0.200 |
Why?
|
| Anti-Infective Agents | 4 | 2013 | 987 | 0.190 |
Why?
|
| Rhinovirus | 4 | 1999 | 210 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2009 | 1348 | 0.190 |
Why?
|
| Breast Feeding | 3 | 2017 | 1365 | 0.190 |
Why?
|
| Thailand | 11 | 2015 | 288 | 0.190 |
Why?
|
| Lamivudine | 4 | 2010 | 368 | 0.190 |
Why?
|
| Immunoglobulin A | 8 | 2000 | 990 | 0.180 |
Why?
|
| Influenza Vaccines | 7 | 2000 | 781 | 0.180 |
Why?
|
| Viral Proteins | 12 | 2001 | 1803 | 0.180 |
Why?
|
| DNA, Viral | 8 | 2015 | 2206 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2008 | 4419 | 0.180 |
Why?
|
| Infant Formula | 2 | 2016 | 195 | 0.180 |
Why?
|
| Measles Vaccine | 4 | 1995 | 79 | 0.170 |
Why?
|
| Pneumocystis Infections | 1 | 1999 | 10 | 0.170 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1390 | 0.170 |
Why?
|
| Growth | 5 | 2006 | 366 | 0.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 540 | 0.170 |
Why?
|
| Pneumocystis | 1 | 1999 | 55 | 0.170 |
Why?
|
| Antigens, CD20 | 1 | 2000 | 199 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 640 | 0.160 |
Why?
|
| Pneumonia, Pneumocystis | 3 | 2001 | 242 | 0.160 |
Why?
|
| Protein-Energy Malnutrition | 2 | 1991 | 189 | 0.160 |
Why?
|
| Ribonucleosides | 3 | 1990 | 79 | 0.160 |
Why?
|
| Nasal Mucosa | 6 | 1985 | 412 | 0.160 |
Why?
|
| Mediastinal Diseases | 1 | 1999 | 91 | 0.160 |
Why?
|
| Immunoglobulins | 3 | 2000 | 856 | 0.160 |
Why?
|
| Virulence | 1 | 2022 | 1303 | 0.160 |
Why?
|
| Ribavirin | 4 | 1990 | 395 | 0.160 |
Why?
|
| Therapeutic Human Experimentation | 1 | 1998 | 43 | 0.160 |
Why?
|
| Bronchiolitis, Viral | 5 | 1981 | 82 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2005 | 828 | 0.150 |
Why?
|
| Pregnancy | 37 | 2017 | 30179 | 0.150 |
Why?
|
| Foscarnet | 1 | 1997 | 36 | 0.150 |
Why?
|
| Retinitis | 1 | 1997 | 36 | 0.140 |
Why?
|
| Female | 114 | 2017 | 396943 | 0.140 |
Why?
|
| Erythema Infectiosum | 1 | 1997 | 15 | 0.140 |
Why?
|
| Antigens, CD19 | 1 | 2000 | 437 | 0.140 |
Why?
|
| Encephalitis, Viral | 1 | 1997 | 58 | 0.140 |
Why?
|
| Immunoenzyme Techniques | 5 | 2000 | 1706 | 0.140 |
Why?
|
| Ganciclovir | 1 | 1997 | 256 | 0.140 |
Why?
|
| Drug Therapy, Combination | 12 | 2009 | 6320 | 0.140 |
Why?
|
| Nurseries, Hospital | 2 | 1988 | 17 | 0.140 |
Why?
|
| Mesoderm | 1 | 2000 | 679 | 0.130 |
Why?
|
| Respiratory System | 5 | 2016 | 565 | 0.130 |
Why?
|
| Diarrhea, Infantile | 1 | 2016 | 100 | 0.130 |
Why?
|
| Measles virus | 3 | 1995 | 67 | 0.130 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 1997 | 217 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2008 | 2030 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1133 | 0.120 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2000 | 365 | 0.120 |
Why?
|
| Vaccination | 9 | 1995 | 3434 | 0.120 |
Why?
|
| Immunization, Passive | 2 | 1993 | 621 | 0.110 |
Why?
|
| Drug Resistance, Viral | 2 | 2010 | 869 | 0.110 |
Why?
|
| Culture Techniques | 12 | 1983 | 530 | 0.110 |
Why?
|
| Pregnant Women | 1 | 1998 | 576 | 0.110 |
Why?
|
| Parvoviridae Infections | 2 | 2006 | 39 | 0.110 |
Why?
|
| Adolescent | 44 | 2009 | 89168 | 0.100 |
Why?
|
| Middle East | 1 | 2013 | 232 | 0.100 |
Why?
|
| Viral Vaccines | 5 | 1993 | 596 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7471 | 0.100 |
Why?
|
| Cross Infection | 4 | 1988 | 1425 | 0.100 |
Why?
|
| Blood | 2 | 1994 | 597 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 5 | 1997 | 592 | 0.100 |
Why?
|
| Influenza A virus | 10 | 1983 | 460 | 0.100 |
Why?
|
| Neutropenia | 2 | 2017 | 892 | 0.100 |
Why?
|
| Pneumonia, Viral | 7 | 1992 | 3240 | 0.100 |
Why?
|
| Parainfluenza Virus 3, Human | 3 | 1987 | 25 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 1993 | 672 | 0.100 |
Why?
|
| Developing Countries | 4 | 1998 | 2901 | 0.100 |
Why?
|
| Receptors, CCR5 | 2 | 2006 | 490 | 0.090 |
Why?
|
| Male | 77 | 2013 | 364781 | 0.090 |
Why?
|
| Syphilis, Congenital | 1 | 1990 | 26 | 0.090 |
Why?
|
| Neutralization Tests | 15 | 1992 | 740 | 0.090 |
Why?
|
| Nasopharynx | 7 | 1986 | 420 | 0.090 |
Why?
|
| Antiviral Agents | 3 | 1997 | 3063 | 0.090 |
Why?
|
| HIV Antigens | 4 | 2001 | 328 | 0.090 |
Why?
|
| Asthma | 10 | 2008 | 6274 | 0.090 |
Why?
|
| Picornaviridae Infections | 2 | 1992 | 97 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2009 | 2538 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2005 | 1355 | 0.080 |
Why?
|
| Enteral Nutrition | 1 | 1995 | 804 | 0.080 |
Why?
|
| Smallpox Vaccine | 7 | 1977 | 77 | 0.080 |
Why?
|
| Virus Cultivation | 11 | 1980 | 88 | 0.080 |
Why?
|
| Lymphocyte Count | 5 | 2008 | 793 | 0.080 |
Why?
|
| Disease Outbreaks | 3 | 1989 | 1764 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 4 | 2006 | 1794 | 0.080 |
Why?
|
| Adult | 52 | 2017 | 223542 | 0.080 |
Why?
|
| Health Occupations | 1 | 1990 | 225 | 0.080 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 1989 | 97 | 0.080 |
Why?
|
| Orthomyxoviridae | 2 | 2000 | 148 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 3854 | 0.070 |
Why?
|
| Zalcitabine | 2 | 1997 | 43 | 0.070 |
Why?
|
| Lymphocyte Subsets | 3 | 2000 | 313 | 0.070 |
Why?
|
| Vaccinia virus | 5 | 1978 | 330 | 0.070 |
Why?
|
| Herpesvirus 3, Human | 3 | 1984 | 159 | 0.070 |
Why?
|
| Mental Processes | 1 | 2009 | 247 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 15965 | 0.070 |
Why?
|
| Drug Administration Schedule | 6 | 2002 | 4861 | 0.070 |
Why?
|
| Cohort Studies | 14 | 2009 | 41797 | 0.070 |
Why?
|
| Immunity, Cellular | 7 | 2000 | 1561 | 0.070 |
Why?
|
| Stem Cells | 1 | 2000 | 3538 | 0.070 |
Why?
|
| Botswana | 3 | 2017 | 1059 | 0.070 |
Why?
|
| Mastitis | 1 | 1986 | 43 | 0.070 |
Why?
|
| Adenoviridae | 5 | 1983 | 1098 | 0.070 |
Why?
|
| Virology | 2 | 2003 | 76 | 0.070 |
Why?
|
| Lymphocyte Activation | 6 | 2005 | 5495 | 0.070 |
Why?
|
| RNA Viruses | 6 | 1980 | 110 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 3 | 2017 | 830 | 0.070 |
Why?
|
| Protective Clothing | 2 | 1988 | 103 | 0.070 |
Why?
|
| Measles | 3 | 1995 | 181 | 0.060 |
Why?
|
| Disease Progression | 11 | 2006 | 13655 | 0.060 |
Why?
|
| Indinavir | 1 | 2005 | 73 | 0.060 |
Why?
|
| Acute Disease | 4 | 2004 | 7246 | 0.060 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2010 | 530 | 0.060 |
Why?
|
| Serotyping | 6 | 1986 | 332 | 0.060 |
Why?
|
| Vaccines, Attenuated | 5 | 1984 | 315 | 0.060 |
Why?
|
| Anemia | 2 | 2013 | 1521 | 0.060 |
Why?
|
| Pancreatitis | 1 | 1992 | 1087 | 0.060 |
Why?
|
| South Africa | 2 | 2008 | 1870 | 0.060 |
Why?
|
| Prospective Studies | 15 | 2013 | 54914 | 0.060 |
Why?
|
| Bacterial Infections | 5 | 1979 | 1397 | 0.060 |
Why?
|
| Seasons | 5 | 2004 | 1526 | 0.060 |
Why?
|
| Paramyxoviridae | 1 | 2004 | 9 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 3 | 1999 | 1081 | 0.060 |
Why?
|
| Coxsackievirus Infections | 2 | 2002 | 45 | 0.060 |
Why?
|
| Monocytes | 3 | 2009 | 2591 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 871 | 0.060 |
Why?
|
| Bronchitis | 5 | 1985 | 196 | 0.060 |
Why?
|
| Child Behavior Disorders | 2 | 2006 | 813 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 1984 | 549 | 0.060 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2005 | 149 | 0.060 |
Why?
|
| HIV Long-Term Survivors | 1 | 2004 | 140 | 0.060 |
Why?
|
| Chickenpox | 1 | 1984 | 96 | 0.050 |
Why?
|
| Time Factors | 17 | 2005 | 40271 | 0.050 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 1980 | 105 | 0.050 |
Why?
|
| Immunodominant Epitopes | 2 | 2004 | 243 | 0.050 |
Why?
|
| HLA-B Antigens | 2 | 2005 | 328 | 0.050 |
Why?
|
| Serologic Tests | 4 | 1993 | 383 | 0.050 |
Why?
|
| Leukocytes | 1 | 1991 | 2030 | 0.050 |
Why?
|
| Interferon Type I | 1 | 1987 | 566 | 0.050 |
Why?
|
| Vaccines | 2 | 1989 | 845 | 0.050 |
Why?
|
| Receptors, Cholinergic | 2 | 1998 | 244 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2006 | 4249 | 0.050 |
Why?
|
| Herpesviridae Infections | 3 | 1999 | 269 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2006 | 673 | 0.050 |
Why?
|
| Immune Sera | 6 | 1989 | 605 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2007 | 913 | 0.050 |
Why?
|
| Otolaryngology | 1 | 1989 | 698 | 0.050 |
Why?
|
| Complement Fixation Tests | 9 | 1978 | 68 | 0.050 |
Why?
|
| Motor Skills | 1 | 2005 | 522 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 1990 | 1494 | 0.050 |
Why?
|
| Virus Shedding | 2 | 1999 | 110 | 0.050 |
Why?
|
| Enterovirus | 2 | 1979 | 69 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2001 | 209 | 0.050 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 1980 | 8 | 0.050 |
Why?
|
| Reye Syndrome | 1 | 1980 | 28 | 0.050 |
Why?
|
| Myasthenia Gravis | 2 | 1998 | 218 | 0.050 |
Why?
|
| Legionnaires' Disease | 1 | 1981 | 50 | 0.050 |
Why?
|
| Epitopes | 6 | 2003 | 2526 | 0.050 |
Why?
|
| Virus Replication | 7 | 2005 | 2459 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2594 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 1894 | 0.040 |
Why?
|
| Double-Blind Method | 6 | 2017 | 12450 | 0.040 |
Why?
|
| Animals | 27 | 2013 | 169418 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2002 | 334 | 0.040 |
Why?
|
| History, 20th Century | 2 | 2005 | 2772 | 0.040 |
Why?
|
| Nucleosides | 1 | 2000 | 131 | 0.040 |
Why?
|
| Child Health Services | 1 | 1985 | 645 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 1980 | 174 | 0.040 |
Why?
|
| Survival Rate | 4 | 2000 | 12875 | 0.040 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1981 | 306 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2010 | 1594 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 1981 | 285 | 0.040 |
Why?
|
| Immunoglobulin G | 10 | 2000 | 4572 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2005 | 14728 | 0.040 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2000 | 240 | 0.040 |
Why?
|
| Masks | 1 | 1981 | 215 | 0.040 |
Why?
|
| Viral Envelope Proteins | 3 | 1988 | 641 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 1992 | 6241 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 14158 | 0.040 |
Why?
|
| Parvovirus B19, Human | 1 | 1998 | 42 | 0.040 |
Why?
|
| Immunoglobulin M | 6 | 2000 | 1529 | 0.040 |
Why?
|
| Lymphadenitis | 1 | 1999 | 99 | 0.040 |
Why?
|
| Postpartum Period | 3 | 2010 | 1197 | 0.040 |
Why?
|
| Amino Acid Sequence | 8 | 2004 | 13452 | 0.040 |
Why?
|
| Haemophilus Infections | 3 | 1976 | 94 | 0.040 |
Why?
|
| Cognition | 3 | 2006 | 7066 | 0.040 |
Why?
|
| Cytopathogenic Effect, Viral | 5 | 1989 | 152 | 0.040 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1998 | 141 | 0.040 |
Why?
|
| Body Composition | 2 | 2001 | 2455 | 0.040 |
Why?
|
| Pneumococcal Vaccines | 1 | 2002 | 414 | 0.040 |
Why?
|
| Cross Reactions | 4 | 1988 | 828 | 0.040 |
Why?
|
| Community-Acquired Infections | 1 | 2002 | 473 | 0.040 |
Why?
|
| Neopterin | 1 | 1997 | 57 | 0.040 |
Why?
|
| Viruses | 4 | 1984 | 373 | 0.040 |
Why?
|
| Lung | 5 | 1992 | 10090 | 0.040 |
Why?
|
| Trachea | 4 | 1978 | 1095 | 0.040 |
Why?
|
| Meningitis, Haemophilus | 1 | 1976 | 20 | 0.040 |
Why?
|
| Blotting, Western | 2 | 1998 | 5042 | 0.040 |
Why?
|
| Streptomycin | 1 | 1976 | 69 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2006 | 1516 | 0.030 |
Why?
|
| Chlamydia Infections | 2 | 1984 | 365 | 0.030 |
Why?
|
| Blood Stains | 1 | 1996 | 8 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1999 | 655 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2000 | 2415 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 1999 | 439 | 0.030 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2000 | 306 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2002 | 6353 | 0.030 |
Why?
|
| Enterovirus Infections | 1 | 1976 | 74 | 0.030 |
Why?
|
| Radiography, Thoracic | 2 | 2000 | 1320 | 0.030 |
Why?
|
| Cartilage | 1 | 2000 | 808 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4586 | 0.030 |
Why?
|
| Microscopy, Electron | 8 | 1983 | 2565 | 0.030 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 3 | 2001 | 215 | 0.030 |
Why?
|
| Species Specificity | 3 | 1998 | 2422 | 0.030 |
Why?
|
| Blood Preservation | 1 | 1996 | 169 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 8 | 1988 | 9263 | 0.030 |
Why?
|
| Ethics, Medical | 2 | 1998 | 785 | 0.030 |
Why?
|
| Myositis | 1 | 1998 | 278 | 0.030 |
Why?
|
| Apnea | 1 | 1977 | 195 | 0.030 |
Why?
|
| Molecular Sequence Data | 7 | 2004 | 17647 | 0.030 |
Why?
|
| Age Distribution | 2 | 2002 | 2881 | 0.030 |
Why?
|
| Sampling Studies | 1 | 1996 | 617 | 0.030 |
Why?
|
| Peptides | 2 | 1985 | 4368 | 0.030 |
Why?
|
| Viral Core Proteins | 3 | 1991 | 158 | 0.030 |
Why?
|
| Area Under Curve | 3 | 2005 | 1640 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2008 | 10125 | 0.030 |
Why?
|
| Puerto Rico | 1 | 1996 | 381 | 0.030 |
Why?
|
| Cardiomyopathies | 2 | 2002 | 2056 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2000 | 3941 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1978 | 794 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2009 | 583 | 0.030 |
Why?
|
| Viruses, Unclassified | 3 | 1969 | 19 | 0.030 |
Why?
|
| Interferons | 1 | 1978 | 714 | 0.030 |
Why?
|
| Antibody Formation | 9 | 1988 | 1393 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1343 | 0.030 |
Why?
|
| Hemagglutination Inhibition Tests | 6 | 1983 | 87 | 0.030 |
Why?
|
| Placebos | 2 | 2015 | 1668 | 0.030 |
Why?
|
| Radioimmunoassay | 3 | 1980 | 862 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2000 | 1335 | 0.030 |
Why?
|
| Blood-Borne Pathogens | 1 | 1994 | 52 | 0.030 |
Why?
|
| Pneumococcal Infections | 2 | 1996 | 529 | 0.030 |
Why?
|
| Immunization | 3 | 1980 | 1220 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1990 | 462 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1996 | 962 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1990 | 1629 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1998 | 1438 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2015 | 326 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1993 | 116 | 0.030 |
Why?
|
| Aerosols | 2 | 1987 | 637 | 0.030 |
Why?
|
| Follow-Up Studies | 8 | 2008 | 39430 | 0.030 |
Why?
|
| HLA-B27 Antigen | 2 | 2004 | 66 | 0.030 |
Why?
|
| Bronchiolitis | 2 | 1991 | 492 | 0.030 |
Why?
|
| Internationality | 1 | 1998 | 1007 | 0.030 |
Why?
|
| Parotitis | 1 | 1972 | 28 | 0.030 |
Why?
|
| gamma-Globulins | 1 | 1972 | 119 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2015 | 65409 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2000 | 19041 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1998 | 1444 | 0.030 |
Why?
|
| Hospitalization | 3 | 2017 | 10845 | 0.030 |
Why?
|
| Longitudinal Studies | 4 | 2009 | 14766 | 0.030 |
Why?
|
| Energy Intake | 2 | 2001 | 2141 | 0.020 |
Why?
|
| Antigens, Surface | 3 | 1989 | 1615 | 0.020 |
Why?
|
| Heart Ventricles | 3 | 2000 | 3839 | 0.020 |
Why?
|
| Counterimmunoelectrophoresis | 3 | 1984 | 14 | 0.020 |
Why?
|
| Risk Factors | 11 | 2010 | 74915 | 0.020 |
Why?
|
| Opportunistic Infections | 2 | 1992 | 376 | 0.020 |
Why?
|
| Amylases | 1 | 1992 | 171 | 0.020 |
Why?
|
| Boston | 4 | 2000 | 9361 | 0.020 |
Why?
|
| Antibody Specificity | 3 | 1998 | 1065 | 0.020 |
Why?
|
| Autoimmune Diseases | 2 | 1998 | 2260 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1998 | 1855 | 0.020 |
Why?
|
| Colorado | 3 | 1980 | 166 | 0.020 |
Why?
|
| Murine hepatitis virus | 4 | 1974 | 19 | 0.020 |
Why?
|
| Human Experimentation | 1 | 1992 | 124 | 0.020 |
Why?
|
| Flow Cytometry | 4 | 2005 | 5904 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 3 | 1992 | 2702 | 0.020 |
Why?
|
| Subacute Sclerosing Panencephalitis | 2 | 1989 | 26 | 0.020 |
Why?
|
| Ligase Chain Reaction | 1 | 2010 | 8 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1998 | 1539 | 0.020 |
Why?
|
| Freezing | 2 | 1982 | 311 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 1991 | 135 | 0.020 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1995 | 925 | 0.020 |
Why?
|
| Nutrition Disorders | 1 | 1991 | 204 | 0.020 |
Why?
|
| Glycoproteins | 3 | 1988 | 2206 | 0.020 |
Why?
|
| Tablets | 1 | 2010 | 149 | 0.020 |
Why?
|
| United States | 10 | 2008 | 73121 | 0.020 |
Why?
|
| Body Weight | 3 | 2006 | 4630 | 0.020 |
Why?
|
| Didanosine | 1 | 2010 | 151 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 1991 | 262 | 0.020 |
Why?
|
| Epidemiologic Methods | 2 | 1985 | 1337 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2008 | 12561 | 0.020 |
Why?
|
| Multiple Sclerosis | 4 | 1978 | 3245 | 0.020 |
Why?
|
| Hemagglutination Tests | 2 | 1980 | 76 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1998 | 935 | 0.020 |
Why?
|
| Lipase | 1 | 1992 | 321 | 0.020 |
Why?
|
| Hepatitis C Antibodies | 1 | 2010 | 151 | 0.020 |
Why?
|
| Methods | 4 | 1984 | 1067 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 1989 | 25 | 0.020 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 1989 | 24 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 1515 | 0.020 |
Why?
|
| Disease Models, Animal | 6 | 1992 | 18388 | 0.020 |
Why?
|
| Pertussis Vaccine | 1 | 1989 | 39 | 0.020 |
Why?
|
| Retroviruses, Simian | 1 | 1989 | 12 | 0.020 |
Why?
|
| Mice | 11 | 1998 | 82045 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 1992 | 666 | 0.020 |
Why?
|
| Labor, Obstetric | 2 | 2004 | 323 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1994 | 1527 | 0.020 |
Why?
|
| Pharyngitis | 2 | 1985 | 222 | 0.020 |
Why?
|
| Specimen Handling | 3 | 1998 | 709 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 2001 | 716 | 0.020 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1989 | 52 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1991 | 762 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2000 | 2589 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1998 | 2131 | 0.020 |
Why?
|
| Erythema | 4 | 1977 | 262 | 0.020 |
Why?
|
| HN Protein | 1 | 1988 | 8 | 0.020 |
Why?
|
| Sexual Partners | 1 | 1994 | 806 | 0.020 |
Why?
|
| Incidence | 3 | 2008 | 21552 | 0.020 |
Why?
|
| Ampicillin | 4 | 1976 | 137 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 1996 | 15460 | 0.020 |
Why?
|
| AIDS Serodiagnosis | 1 | 1990 | 220 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 1989 | 189 | 0.020 |
Why?
|
| Viral Fusion Proteins | 2 | 1987 | 100 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2005 | 7451 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 1977 | 1172 | 0.020 |
Why?
|
| Cell Line | 9 | 2002 | 15609 | 0.020 |
Why?
|
| Gloves, Surgical | 1 | 1988 | 24 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1989 | 491 | 0.020 |
Why?
|
| HIV-2 | 1 | 1989 | 156 | 0.020 |
Why?
|
| Heart | 2 | 1992 | 4451 | 0.020 |
Why?
|
| Administration, Oral | 3 | 2010 | 4041 | 0.020 |
Why?
|
| Retrospective Studies | 7 | 2006 | 81834 | 0.020 |
Why?
|
| Bronchi | 1 | 1992 | 847 | 0.020 |
Why?
|
| Drug Interactions | 2 | 2004 | 1421 | 0.020 |
Why?
|
| Visitors to Patients | 1 | 1988 | 36 | 0.020 |
Why?
|
| Myocardium | 2 | 1992 | 4788 | 0.020 |
Why?
|
| Respiratory Protective Devices | 1 | 1988 | 47 | 0.020 |
Why?
|
| Bacteria | 2 | 2016 | 2226 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2000 | 3335 | 0.020 |
Why?
|
| Weight Gain | 2 | 1995 | 2357 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 1991 | 487 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1991 | 1604 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 1993 | 15638 | 0.020 |
Why?
|
| Risk | 3 | 2001 | 9642 | 0.020 |
Why?
|
| Haplorhini | 4 | 1979 | 524 | 0.020 |
Why?
|
| New Jersey | 2 | 1977 | 295 | 0.020 |
Why?
|
| Health Policy | 1 | 2000 | 2699 | 0.020 |
Why?
|
| Echocardiography | 4 | 1998 | 5043 | 0.020 |
Why?
|
| Gestational Age | 3 | 2004 | 3615 | 0.020 |
Why?
|
| Plasma | 1 | 2010 | 588 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1998 | 2145 | 0.020 |
Why?
|
| Injections, Intradermal | 5 | 1977 | 116 | 0.020 |
Why?
|
| Mutation | 5 | 2005 | 30243 | 0.020 |
Why?
|
| Heart Arrest | 2 | 1994 | 1516 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1976 | 1988 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1992 | 960 | 0.020 |
Why?
|
| Neutrophils | 2 | 2006 | 3790 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 1988 | 446 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2005 | 1869 | 0.020 |
Why?
|
| Linear Models | 1 | 1996 | 5880 | 0.020 |
Why?
|
| Cytomegalovirus | 3 | 1998 | 755 | 0.020 |
Why?
|
| Thiocyanates | 1 | 1986 | 70 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 1992 | 867 | 0.020 |
Why?
|
| Pediatrics | 1 | 1981 | 3622 | 0.020 |
Why?
|
| Time | 1 | 2008 | 546 | 0.020 |
Why?
|
| AIDS Dementia Complex | 2 | 1998 | 154 | 0.020 |
Why?
|
| Nucleoproteins | 2 | 1985 | 110 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1986 | 236 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1986 | 222 | 0.020 |
Why?
|
| Tonsillitis | 1 | 1985 | 28 | 0.020 |
Why?
|
| Tracheitis | 1 | 1985 | 29 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1980 | 342 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2006 | 402 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 1998 | 8051 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1986 | 455 | 0.020 |
Why?
|
| Canada | 1 | 1991 | 2143 | 0.020 |
Why?
|
| Molecular Weight | 3 | 1988 | 2173 | 0.020 |
Why?
|
| Variola virus | 4 | 1977 | 12 | 0.020 |
Why?
|
| Haemophilus influenzae | 2 | 1976 | 178 | 0.020 |
Why?
|
| Physicians' Offices | 1 | 1985 | 60 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 1989 | 648 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 1994 | 1244 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 1994 | 922 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 4220 | 0.010 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1984 | 55 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2008 | 676 | 0.010 |
Why?
|
| Antigens | 2 | 1971 | 1443 | 0.010 |
Why?
|
| Simian immunodeficiency virus | 1 | 1989 | 814 | 0.010 |
Why?
|
| Fever | 3 | 1994 | 1622 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 1983 | 359 | 0.010 |
Why?
|
| Vocabulary | 1 | 2005 | 167 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1991 | 1797 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2103 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 13497 | 0.010 |
Why?
|
| Muscles | 1 | 1989 | 1582 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6242 | 0.010 |
Why?
|
| Intubation | 1 | 1984 | 140 | 0.010 |
Why?
|
| Interferon-gamma | 2 | 2003 | 3169 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 363 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1992 | 1814 | 0.010 |
Why?
|
| Parturition | 1 | 2007 | 453 | 0.010 |
Why?
|
| Urine | 2 | 1998 | 363 | 0.010 |
Why?
|
| Electrocardiography | 3 | 1994 | 6410 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2000 | 317 | 0.010 |
Why?
|
| Half-Life | 1 | 2004 | 650 | 0.010 |
Why?
|
| Respiration | 2 | 2000 | 1667 | 0.010 |
Why?
|
| Anthropometry | 2 | 2001 | 1343 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1989 | 2079 | 0.010 |
Why?
|
| Culture Media | 3 | 1988 | 899 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1983 | 213 | 0.010 |
Why?
|
| Hepacivirus | 1 | 2010 | 1342 | 0.010 |
Why?
|
| Multivariate Analysis | 3 | 2002 | 12096 | 0.010 |
Why?
|
| Biological Products | 1 | 1992 | 937 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1971 | 1898 | 0.010 |
Why?
|
| Reference Values | 1 | 2009 | 4941 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2008 | 1081 | 0.010 |
Why?
|
| Antibodies, Bacterial | 2 | 1981 | 1481 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2000 | 11674 | 0.010 |
Why?
|
| Phenotype | 2 | 2002 | 16712 | 0.010 |
Why?
|
| Mycoplasma Infections | 2 | 1979 | 120 | 0.010 |
Why?
|
| Adenosine Deaminase | 1 | 1984 | 253 | 0.010 |
Why?
|
| Giant Cells | 1 | 2002 | 188 | 0.010 |
Why?
|
| Pregnancy Outcome | 2 | 2004 | 2959 | 0.010 |
Why?
|
| Colostrum | 1 | 1981 | 28 | 0.010 |
Why?
|
| Antigenic Variation | 1 | 2001 | 118 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1989 | 1795 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2006 | 756 | 0.010 |
Why?
|
| Rifabutin | 1 | 2001 | 59 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 2 | 1991 | 1207 | 0.010 |
Why?
|
| Legionella | 1 | 1981 | 27 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 30028 | 0.010 |
Why?
|
| Massachusetts | 2 | 1996 | 8908 | 0.010 |
Why?
|
| Young Adult | 3 | 2015 | 60045 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1982 | 262 | 0.010 |
Why?
|
| HLA-B7 Antigen | 1 | 2000 | 48 | 0.010 |
Why?
|
| Intelligence | 1 | 2006 | 929 | 0.010 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2001 | 99 | 0.010 |
Why?
|
| Gene Products, nef | 1 | 2000 | 102 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 1980 | 128 | 0.010 |
Why?
|
| Logistic Models | 2 | 2007 | 13324 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2006 | 1532 | 0.010 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 149 | 0.010 |
Why?
|
| Nose | 1 | 1984 | 524 | 0.010 |
Why?
|
| Encephalitis | 2 | 1978 | 441 | 0.010 |
Why?
|
| Age Factors | 5 | 1999 | 18478 | 0.010 |
Why?
|
| Autoradiography | 2 | 1990 | 732 | 0.010 |
Why?
|
| Tetracyclines | 2 | 1976 | 64 | 0.010 |
Why?
|
| Chloramphenicol | 2 | 1976 | 67 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1980 | 139 | 0.010 |
Why?
|
| Body Height | 1 | 2006 | 1568 | 0.010 |
Why?
|
| Sputum | 2 | 1979 | 511 | 0.010 |
Why?
|
| Complement Activation | 1 | 1981 | 448 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 236 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2000 | 214 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1998 | 114 | 0.010 |
Why?
|
| Child Behavior | 1 | 2005 | 862 | 0.010 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 1998 | 28 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 257 | 0.010 |
Why?
|
| Aging | 3 | 2000 | 8761 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2826 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4780 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 1999 | 216 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2000 | 406 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 1999 | 255 | 0.010 |
Why?
|
| Rubella | 1 | 1978 | 55 | 0.010 |
Why?
|
| Egg White | 1 | 1977 | 16 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2003 | 977 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 1009 | 0.010 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1977 | 75 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 2005 | 7134 | 0.010 |
Why?
|
| Base Sequence | 2 | 2003 | 12428 | 0.010 |
Why?
|
| Oropharynx | 1 | 1998 | 138 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1998 | 111 | 0.010 |
Why?
|
| HIV Seroprevalence | 1 | 1998 | 89 | 0.010 |
Why?
|
| Torpedo | 1 | 1998 | 170 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2000 | 5152 | 0.010 |
Why?
|
| Herpes Simplex | 2 | 1978 | 470 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 1985 | 2733 | 0.010 |
Why?
|
| Ecology | 1 | 1978 | 105 | 0.010 |
Why?
|
| Rotavirus | 1 | 1978 | 110 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1989 | 10273 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1983 | 749 | 0.010 |
Why?
|
| Uterine Hemorrhage | 1 | 1998 | 240 | 0.010 |
Why?
|
| Perinatal Care | 1 | 1999 | 245 | 0.010 |
Why?
|
| Cell Survival | 1 | 1987 | 5801 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 3624 | 0.010 |
Why?
|
| Antibodies | 3 | 1977 | 2425 | 0.010 |
Why?
|
| Penicillin Resistance | 1 | 1976 | 77 | 0.010 |
Why?
|
| Immunoassay | 1 | 1980 | 746 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1979 | 903 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 2286 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 1998 | 238 | 0.010 |
Why?
|
| Enterovirus B, Human | 1 | 1976 | 49 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1977 | 94 | 0.010 |
Why?
|
| Milk, Human | 1 | 1981 | 489 | 0.010 |
Why?
|
| Hybridomas | 1 | 1998 | 444 | 0.010 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 1980 | 450 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2433 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1977 | 557 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1987 | 3713 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 1305 | 0.010 |
Why?
|
| Child, Hospitalized | 1 | 1978 | 182 | 0.010 |
Why?
|
| Pharynx | 2 | 1979 | 436 | 0.010 |
Why?
|
| Solubility | 2 | 1988 | 1086 | 0.010 |
Why?
|
| Adenoviridae Infections | 2 | 1973 | 96 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 6856 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 792 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 1543 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1977 | 678 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1744 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2006 | 2485 | 0.010 |
Why?
|
| Skin Tests | 1 | 1977 | 639 | 0.010 |
Why?
|
| Carrier State | 1 | 1979 | 529 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 9687 | 0.010 |
Why?
|
| Aged | 3 | 2005 | 171520 | 0.010 |
Why?
|
| Genotype | 2 | 2000 | 13047 | 0.010 |
Why?
|
| Kidney | 4 | 1979 | 7064 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1995 | 187 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1990 | 4533 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 1999 | 1998 | 0.010 |
Why?
|
| Laryngismus | 1 | 1974 | 28 | 0.010 |
Why?
|
| Phosphorus Isotopes | 2 | 1971 | 125 | 0.010 |
Why?
|
| Reference Standards | 1 | 1998 | 1015 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 1992 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1971 | 298 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2002 | 22293 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 808 | 0.010 |
Why?
|
| Lincomycin | 1 | 1973 | 5 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 1975 | 146 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 2846 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 4545 | 0.010 |
Why?
|
| Lipids | 2 | 1978 | 3346 | 0.010 |
Why?
|
| Bacteroides Infections | 1 | 1973 | 89 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1978 | 796 | 0.010 |
Why?
|
| Isoleucine | 1 | 1993 | 112 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1980 | 3635 | 0.010 |
Why?
|
| Frontal Sinus | 1 | 1973 | 51 | 0.010 |
Why?
|
| Capsid | 2 | 1987 | 437 | 0.010 |
Why?
|
| Epithelium | 1 | 1978 | 1610 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1974 | 160 | 0.010 |
Why?
|
| Gels | 2 | 1971 | 421 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1973 | 278 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1977 | 1697 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2000 | 1159 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1998 | 2224 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1999 | 3615 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 15880 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1976 | 694 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1977 | 1820 | 0.010 |
Why?
|
| Platelet Adhesiveness | 1 | 1973 | 154 | 0.010 |
Why?
|
| Tympanic Membrane | 1 | 1974 | 232 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 1974 | 485 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1973 | 131 | 0.010 |
Why?
|
| Brain Abscess | 1 | 1973 | 123 | 0.010 |
Why?
|
| Streptococcal Infections | 2 | 1976 | 619 | 0.010 |
Why?
|
| Inflammation | 1 | 1992 | 10865 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1998 | 1251 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1979 | 2363 | 0.010 |
Why?
|
| Maxillary Sinus | 1 | 1973 | 176 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1973 | 1310 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1978 | 13026 | 0.010 |
Why?
|
| Leucine | 1 | 1993 | 549 | 0.010 |
Why?
|
| Temperature | 2 | 1978 | 2237 | 0.010 |
Why?
|
| Xylose | 1 | 1991 | 28 | 0.010 |
Why?
|
| Tachycardia | 1 | 1994 | 599 | 0.010 |
Why?
|
| Cesium | 1 | 1971 | 36 | 0.010 |
Why?
|
| Proline | 1 | 1993 | 456 | 0.010 |
Why?
|
| Lactose Intolerance | 1 | 1991 | 28 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1971 | 213 | 0.010 |
Why?
|
| Brain | 2 | 1989 | 27438 | 0.010 |
Why?
|
| Injections, Subcutaneous | 3 | 1977 | 681 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1977 | 712 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1992 | 528 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1971 | 294 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 1975 | 577 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1992 | 575 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1980 | 3664 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 3742 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1971 | 641 | 0.010 |
Why?
|
| Glycolipids | 1 | 1971 | 206 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1971 | 459 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1990 | 96 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 1223 | 0.010 |
Why?
|
| Lymphocytes | 3 | 1992 | 2611 | 0.010 |
Why?
|
| Esters | 1 | 1971 | 212 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 1972 | 371 | 0.010 |
Why?
|
| Silicon Dioxide | 1 | 1971 | 218 | 0.010 |
Why?
|
| Breath Tests | 1 | 1991 | 300 | 0.010 |
Why?
|
| Solvents | 1 | 1971 | 298 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1992 | 591 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1976 | 1510 | 0.010 |
Why?
|
| Blood Donors | 1 | 1992 | 345 | 0.010 |
Why?
|
| Cattle | 2 | 1977 | 3830 | 0.010 |
Why?
|
| Chronic Disease | 3 | 2000 | 9382 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1991 | 642 | 0.010 |
Why?
|
| Hot Temperature | 2 | 1973 | 1439 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2000 | 4029 | 0.010 |
Why?
|
| Acetates | 1 | 1971 | 318 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1991 | 367 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1971 | 394 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1975 | 1150 | 0.010 |
Why?
|
| Gene Products, env | 1 | 1990 | 250 | 0.010 |
Why?
|
| Cilia | 2 | 1978 | 499 | 0.010 |
Why?
|
| Middle Aged | 8 | 2006 | 223418 | 0.000 |
Why?
|
| Alleles | 1 | 1999 | 6890 | 0.000 |
Why?
|
| Receptors, HIV | 1 | 1989 | 159 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2006 | 13030 | 0.000 |
Why?
|
| Heart Rate | 1 | 2000 | 4218 | 0.000 |
Why?
|
| Chlorides | 1 | 1971 | 663 | 0.000 |
Why?
|
| Hypotension | 1 | 1994 | 888 | 0.000 |
Why?
|
| Morbidity | 1 | 1993 | 1760 | 0.000 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1970 | 255 | 0.000 |
Why?
|
| Phosphates | 1 | 1971 | 767 | 0.000 |
Why?
|
| Phospholipids | 1 | 1971 | 783 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1978 | 1668 | 0.000 |
Why?
|
| Cell Extracts | 1 | 1987 | 135 | 0.000 |
Why?
|
| Convalescence | 1 | 1967 | 109 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1990 | 1650 | 0.000 |
Why?
|
| Rats, Inbred Lew | 1 | 1988 | 1165 | 0.000 |
Why?
|
| Growth Disorders | 1 | 1991 | 635 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2007 | 24311 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1990 | 1133 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1991 | 1727 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1971 | 1100 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4213 | 0.000 |
Why?
|
| Intestines | 1 | 1974 | 1912 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1993 | 3973 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1984 | 30 | 0.000 |
Why?
|
| Complement Activating Enzymes | 1 | 1984 | 22 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 10358 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1984 | 114 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1734 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 548 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4120 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1977 | 2816 | 0.000 |
Why?
|
| Rabbits | 1 | 1971 | 4786 | 0.000 |
Why?
|
| Complement C1q | 1 | 1984 | 93 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1974 | 4180 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1973 | 1412 | 0.000 |
Why?
|
| Herpes Genitalis | 1 | 1984 | 149 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1993 | 2258 | 0.000 |
Why?
|
| Triglycerides | 1 | 1971 | 2465 | 0.000 |
Why?
|
| Chlamydia trachomatis | 1 | 1984 | 239 | 0.000 |
Why?
|
| Cholesterol | 1 | 1971 | 2910 | 0.000 |
Why?
|
| Complement C3b | 1 | 1981 | 98 | 0.000 |
Why?
|
| Immunologic Memory | 1 | 1988 | 1375 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1981 | 294 | 0.000 |
Why?
|
| Kinetics | 1 | 1988 | 6348 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1990 | 6527 | 0.000 |
Why?
|
| Liver | 1 | 1996 | 7575 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1998 | 22365 | 0.000 |
Why?
|
| Swine | 2 | 1978 | 5996 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1990 | 4417 | 0.000 |
Why?
|
| Kentucky | 1 | 1977 | 84 | 0.000 |
Why?
|
| Military Medicine | 1 | 1979 | 185 | 0.000 |
Why?
|
| Smallpox | 1 | 1977 | 43 | 0.000 |
Why?
|
| Minnesota | 1 | 1977 | 338 | 0.000 |
Why?
|
| Swine Diseases | 1 | 1976 | 61 | 0.000 |
Why?
|
| Transplantation, Homologous | 2 | 1976 | 4834 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1976 | 385 | 0.000 |
Why?
|
| Lung Diseases, Fungal | 1 | 1976 | 125 | 0.000 |
Why?
|
| Karyotyping | 1 | 1976 | 1173 | 0.000 |
Why?
|
| Nitrofurantoin | 1 | 1973 | 18 | 0.000 |
Why?
|
| Kanamycin | 1 | 1973 | 63 | 0.000 |
Why?
|
| Erythromycin | 1 | 1973 | 115 | 0.000 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1973 | 71 | 0.000 |
Why?
|
| Clindamycin | 1 | 1973 | 139 | 0.000 |
Why?
|
| California | 1 | 1977 | 1444 | 0.000 |
Why?
|
| Histocompatibility | 1 | 1973 | 322 | 0.000 |
Why?
|
| Rats | 1 | 1988 | 23839 | 0.000 |
Why?
|
| Urticaria | 1 | 1973 | 151 | 0.000 |
Why?
|
| Acrylates | 1 | 1971 | 75 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1971 | 226 | 0.000 |
Why?
|
| Otitis Media | 1 | 1973 | 288 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1971 | 292 | 0.000 |
Why?
|
| World Health Organization | 1 | 1977 | 1328 | 0.000 |
Why?
|
| Sucrose | 1 | 1971 | 159 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1977 | 2362 | 0.000 |
Why?
|
| Syndrome | 1 | 1976 | 3278 | 0.000 |
Why?
|
| Glycerol | 1 | 1971 | 275 | 0.000 |
Why?
|
| Deoxyuridine | 1 | 1969 | 34 | 0.000 |
Why?
|
| Chloroform | 1 | 1969 | 31 | 0.000 |
Why?
|
| Autopsy | 1 | 1973 | 1013 | 0.000 |
Why?
|
| Heart Failure | 1 | 1993 | 11857 | 0.000 |
Why?
|
| Bile Acids and Salts | 1 | 1971 | 398 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1976 | 2929 | 0.000 |
Why?
|
| Nucleic Acids | 1 | 1969 | 190 | 0.000 |
Why?
|
| Mouth Neoplasms | 1 | 1971 | 598 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1967 | 978 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1971 | 3090 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1969 | 2488 | 0.000 |
Why?
|
| Sinusitis | 1 | 1973 | 995 | 0.000 |
Why?
|
| Morphogenesis | 1 | 1967 | 747 | 0.000 |
Why?
|
| Public Health | 1 | 1977 | 2693 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1969 | 1674 | 0.000 |
Why?
|
| Radiography | 1 | 1973 | 6995 | 0.000 |
Why?
|
| Carcinoma | 1 | 1971 | 2341 | 0.000 |
Why?
|
| Smoking | 1 | 1976 | 9099 | 0.000 |
Why?
|